Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2020 747
2021 1000
2022 584
2023 299
2024 55

Text availability

Article attribute

Article type

Publication date

Search Results

2,397 results

Results by year

Filters applied: . Clear all
Page 1
Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection.
Kumar NR, Karanam VC, Kumar S, Kumar SD. Kumar NR, et al. South Med J. 2023 May;116(5):427-433. doi: 10.14423/SMJ.0000000000001546. South Med J. 2023. PMID: 37137479 Free PMC article. Review.
We investigated the safety and efficacy of convalescent plasma in specifically late-stage (designated as after 2 weeks of hospital admission) severe COVID-19 infection. ...RESULTS: Eight ICU patients received plasma late in the course of COVI …
We investigated the safety and efficacy of convalescent plasma in specifically late-stage (designated as after 2 weeks of hosp …
Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
Hosseini P, Rahimi H, Najafabadi MM, Ghorbani A, Najafabadi SK, Faridzadeh A, Arabpour J, Khormali E, Deravi N. Hosseini P, et al. Acta Med Indones. 2021 Jan;53(1):86-95. Acta Med Indones. 2021. PMID: 33818411 Free article. Review.
The global widespread mortality after the emergence of SARS-CoV-2 infection in China, has become a critical concern all around the world. Convalescent plasma (CP) therapy is one of the methods elevating the survival rate for COVID- …
The global widespread mortality after the emergence of SARS-CoV-2 infection in China, has become a critical concern all …
Convalescent plasma and hyperimmune globulin therapy in COVID-19.
Cagdas D. Cagdas D. Expert Rev Clin Immunol. 2021 Apr;17(4):309-316. doi: 10.1080/1744666X.2021.1894927. Epub 2021 Mar 12. Expert Rev Clin Immunol. 2021. PMID: 33620014 Review.
Introduction: Severe acute respiratory syndrome causing coronavirus SARS-CoV-2 (coronavirus disease 2019 (COVID-19)) has recently resulted in the recent global pandemic. ...Medical literature is reviewed for randomized controlled studies using …
Introduction: Severe acute respiratory syndrome causing coronavirus SARS-CoV-2 (coronavirus disease 2019 (COVID- …
Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results.
Oliveira FA, Nucci MP, Rego GNA, Alves ADH, Marti LC, Nucci LP, Mamani JB, Gamarra LF. Oliveira FA, et al. Einstein (Sao Paulo). 2021 Apr 19;19:eRW6186. doi: 10.31744/einstein_journal/2021RW6186. eCollection 2021. Einstein (Sao Paulo). 2021. PMID: 33886937 Free PMC article. Review.
The objective of this study was to highlight the global scientific effort to fight the SARS-CoV-2, addressing the preliminary results of passive immunization through convalescent plasma. We performed a search at the major databases …
The objective of this study was to highlight the global scientific effort to fight the SARS-CoV-2, addressing the preli …
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy.
Casadevall A, Joyner MJ, Pirofski LA, Senefeld JW, Shoham S, Sullivan D, Paneth N, Focosi D. Casadevall A, et al. Expert Rev Respir Med. 2023 May;17(5):381-395. doi: 10.1080/17476348.2023.2208349. Epub 2023 May 2. Expert Rev Respir Med. 2023. PMID: 37129285 Review.
INTRODUCTION: When the COVID-19 pandemic struck no specific therapies were available and many turned to COVID-19 convalescent plasma (CCP), a form of antibody therapy. ...However, COVID-19 in immunocompromised patient …
INTRODUCTION: When the COVID-19 pandemic struck no specific therapies were available and many turned to COVID-19 …
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
Majumder J, Minko T. Majumder J, et al. AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2. AAPS J. 2021. PMID: 33400058 Free PMC article. Review.
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide with millions of people at risk in a growing number of count …
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 ( …
Different aspects of convalescent plasma therapy for COVID-19 treatment; a critical review.
Khadka S, Nisar S, Syed NI, Shrestha DB, Budhathoki P. Khadka S, et al. Immunopharmacol Immunotoxicol. 2021 Feb;43(1):30-36. doi: 10.1080/08923973.2020.1863983. Epub 2020 Dec 27. Immunopharmacol Immunotoxicol. 2021. PMID: 33356684 Review.
The novel coronavirus disease (COVID-19) has been declared a pandemic by the World Health Organization (WHO) and is ominously threatening the survival of humankind on the whole planet. ...Although recent studies have shown benefits in decreasing the severity and dur …
The novel coronavirus disease (COVID-19) has been declared a pandemic by the World Health Organization (WHO) and is ominously …
Convalescent plasma therapy in patients with COVID-19.
Altuntas F, Ata N, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Kınık K, Haznedaroglu İ, Yılmaz FM, Kılıç İ, Demircioğlu S, Yosunkaya A, Erkurt MA, Turgut B, Caglayan M, Celik O. Altuntas F, et al. Transfus Apher Sci. 2021 Feb;60(1):102955. doi: 10.1016/j.transci.2020.102955. Epub 2020 Sep 19. Transfus Apher Sci. 2021. PMID: 33011076 Free PMC article.
In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and critically ill patients diagnosed with COVID-19. METHOD: The data of severe or critically ill COVID-19 patients who received anti …
In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and critically ill pa …
Convalescent Plasma Therapy against COVID-19: An Update on the Changing Facets of the ongoing Pandemic.
Abullais SS, Arora S, Wahab S, Grover V, Alshahrani MY, Shamsudeen SM, Mohammed Asif S, Faragalla AI, Elagib MF. Abullais SS, et al. Curr Pharm Biotechnol. 2023;24(12):1515-1523. doi: 10.2174/1389201024666230202144314. Curr Pharm Biotechnol. 2023. PMID: 36733203
In the wake of the recent emerging wave of the pandemic viz omicron variant, changing facets of the viral genome and dearth of preventative and therapeutic possibilities for the management of COVID-19, the usage of Convalescent Plasma Therapy (C …
In the wake of the recent emerging wave of the pandemic viz omicron variant, changing facets of the viral genome and dearth of preventative …
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.
Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S, Grossman BJ, Henderson JP, Musser J, Salazar E, Hartman WR, Bouvier NM, Liu STH, Pirofski LA, Baker SE, van Helmond N, Wright RS, Fairweather D, Bruno KA, Wang Z, Paneth NS, Casadevall A, Joyner MJ. Klassen SA, et al. Mayo Clin Proc. 2021 May;96(5):1262-1275. doi: 10.1016/j.mayocp.2021.02.008. Epub 2021 Feb 17. Mayo Clin Proc. 2021. PMID: 33958057 Free PMC article. Review.
To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose-response studies, and 96 case reports or case series. ...Random effects anal …
To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated patient outcome data from 10 …
2,397 results